A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Phendimetrazine
Dimetacrine
Potassium may increase the excretion rate of Dimetacrine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Macitentan
Potassium may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Trametinib
Potassium may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Glycerol phenylbutyrate
Potassium may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Formestane
Potassium may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Certolizumab pegol
Potassium may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Teduglutide
Potassium may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Aclidinium
Potassium may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Peginesatide
Potassium may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Ruxolitinib
Potassium may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Deferiprone
Potassium may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Tiopronin
Potassium may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Plerixafor
Potassium may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Methylnaltrexone
Potassium may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Dimercaprol
Potassium may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Gadofosveset trisodium
Potassium may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Desvenlafaxine
Potassium may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Flupirtine
Potassium may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Telavancin
Potassium may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Nalmefene
Potassium may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3